USA Prescription Gastrointestinal Drugs Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Prescription Gastrointestinal Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Prescription Gastrointestinal Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Prescription Gastrointestinal Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Salix Pharmaceuticals

    • GlaxoSmithKline

    • Eisai

    • Axcan Pharmaceuticals

    • Merck

    • AstraZeneca

    By Type:

    • Oral

    • Topical

    By End-User:

    • Hospital Pharmacies

    • Online Pharmacies

    • Retail Pharmacies

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Prescription Gastrointestinal Drugs Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Prescription Gastrointestinal Drugs Market Size and Growth Rate of Oral from 2016 to 2027

      • 1.3.2 USA Prescription Gastrointestinal Drugs Market Size and Growth Rate of Topical from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Prescription Gastrointestinal Drugs Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027

      • 1.4.2 USA Prescription Gastrointestinal Drugs Market Size and Growth Rate of Online Pharmacies from 2016 to 2027

      • 1.4.3 USA Prescription Gastrointestinal Drugs Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Prescription Gastrointestinal Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Prescription Gastrointestinal Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Oral

      • 3.4.2 Market Size and Growth Rate of Topical

    4 Segmentation of Prescription Gastrointestinal Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Prescription Gastrointestinal Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Prescription Gastrointestinal Drugs in Hospital Pharmacies

      • 4.4.2 Market Size and Growth Rate of Prescription Gastrointestinal Drugs in Online Pharmacies

      • 4.4.3 Market Size and Growth Rate of Prescription Gastrointestinal Drugs in Retail Pharmacies

    5 Market Analysis by Regions

    • 5.1 USA Prescription Gastrointestinal Drugs Production Analysis by Regions

    • 5.2 USA Prescription Gastrointestinal Drugs Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Prescription Gastrointestinal Drugs Landscape Analysis

    • 6.1 West USA Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 6.2 West USA Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    7 South USA Prescription Gastrointestinal Drugs Landscape Analysis

    • 7.1 South USA Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 7.2 South USA Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    8 Middle West USA Prescription Gastrointestinal Drugs Landscape Analysis

    • 8.1 Middle West USA Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 8.2 Middle West USA Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    9 Northeast USA Prescription Gastrointestinal Drugs Landscape Analysis

    • 9.1 Northeast USA Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 9.2 Northeast USA Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Salix Pharmaceuticals

        • 10.1.1 Salix Pharmaceuticals Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 GlaxoSmithKline

        • 10.2.1 GlaxoSmithKline Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Eisai

        • 10.3.1 Eisai Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Axcan Pharmaceuticals

        • 10.4.1 Axcan Pharmaceuticals Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Merck

        • 10.5.1 Merck Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 AstraZeneca

        • 10.6.1 AstraZeneca Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Prescription Gastrointestinal Drugs Market Size and Growth Rate of Oral from 2016 to 2027

    • Figure USA Prescription Gastrointestinal Drugs Market Size and Growth Rate of Topical from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Prescription Gastrointestinal Drugs Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027

    • Figure USA Prescription Gastrointestinal Drugs Market Size and Growth Rate of Online Pharmacies from 2016 to 2027

    • Figure USA Prescription Gastrointestinal Drugs Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Prescription Gastrointestinal Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Prescription Gastrointestinal Drugs

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Prescription Gastrointestinal Drugs by Different Types from 2016 to 2027

    • Table Consumption Share of Prescription Gastrointestinal Drugs by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Oral

    • Figure Market Size and Growth Rate of Topical

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Prescription Gastrointestinal Drugs by Different End-Users from 2016 to 2027

    • Table Consumption Share of Prescription Gastrointestinal Drugs by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospital Pharmacies

    • Figure Market Size and Growth Rate of Online Pharmacies

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Table USA Prescription Gastrointestinal Drugs Production by Regions

    • Table USA Prescription Gastrointestinal Drugs Production Share by Regions

    • Figure USA Prescription Gastrointestinal Drugs Production Share by Regions in 2016

    • Figure USA Prescription Gastrointestinal Drugs Production Share by Regions in 2021

    • Figure USA Prescription Gastrointestinal Drugs Production Share by Regions in 2027

    • Table USA Prescription Gastrointestinal Drugs Consumption by Regions

    • Table USA Prescription Gastrointestinal Drugs Consumption Share by Regions

    • Figure USA Prescription Gastrointestinal Drugs Consumption Share by Regions in 2016

    • Figure USA Prescription Gastrointestinal Drugs Consumption Share by Regions in 2021

    • Figure USA Prescription Gastrointestinal Drugs Consumption Share by Regions in 2027

    • Table West USA Prescription Gastrointestinal Drugs Consumption by Types from 2016 to 2027

    • Table West USA Prescription Gastrointestinal Drugs Consumption Share by Types from 2016 to 2027

    • Figure West USA Prescription Gastrointestinal Drugs Consumption Share by Types in 2016

    • Figure West USA Prescription Gastrointestinal Drugs Consumption Share by Types in 2021

    • Figure West USA Prescription Gastrointestinal Drugs Consumption Share by Types in 2027

    • Table West USA Prescription Gastrointestinal Drugs Consumption by End-Users from 2016 to 2027

    • Table West USA Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2016

    • Figure West USA Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2021

    • Figure West USA Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2027

    • Table South USA Prescription Gastrointestinal Drugs Consumption by Types from 2016 to 2027

    • Table South USA Prescription Gastrointestinal Drugs Consumption Share by Types from 2016 to 2027

    • Figure South USA Prescription Gastrointestinal Drugs Consumption Share by Types in 2016

    • Figure South USA Prescription Gastrointestinal Drugs Consumption Share by Types in 2021

    • Figure South USA Prescription Gastrointestinal Drugs Consumption Share by Types in 2027

    • Table South USA Prescription Gastrointestinal Drugs Consumption by End-Users from 2016 to 2027

    • Table South USA Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2016

    • Figure South USA Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2021

    • Figure South USA Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2027

    • Table Middle West USA Prescription Gastrointestinal Drugs Consumption by Types from 2016 to 2027

    • Table Middle West USA Prescription Gastrointestinal Drugs Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Prescription Gastrointestinal Drugs Consumption Share by Types in 2016

    • Figure Middle West USA Prescription Gastrointestinal Drugs Consumption Share by Types in 2021

    • Figure Middle West USA Prescription Gastrointestinal Drugs Consumption Share by Types in 2027

    • Table Middle West USA Prescription Gastrointestinal Drugs Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2016

    • Figure Middle West USA Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2021

    • Figure Middle West USA Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2027

    • Table Northeast USA Prescription Gastrointestinal Drugs Consumption by Types from 2016 to 2027

    • Table Northeast USA Prescription Gastrointestinal Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Prescription Gastrointestinal Drugs Consumption Share by Types in 2016

    • Figure Northeast USA Prescription Gastrointestinal Drugs Consumption Share by Types in 2021

    • Figure Northeast USA Prescription Gastrointestinal Drugs Consumption Share by Types in 2027

    • Table Northeast USA Prescription Gastrointestinal Drugs Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2016

    • Figure Northeast USA Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2021

    • Figure Northeast USA Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Salix Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Salix Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Salix Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Salix Pharmaceuticals

    • Table Product and Service Introduction of Salix Pharmaceuticals

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Eisai

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai

    • Figure Sales and Growth Rate Analysis of Eisai

    • Figure Revenue and Market Share Analysis of Eisai

    • Table Product and Service Introduction of Eisai

    • Table Company Profile and Development Status of Axcan Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Axcan Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Axcan Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Axcan Pharmaceuticals

    • Table Product and Service Introduction of Axcan Pharmaceuticals

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.